Method of evaluating prostatic disease
US9465031B2 · kind B2 · utility
0Cited by
5References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 17, 2010 |
| Grant date | Oct 11, 2016 |
| Priority date | — |
| Expiry date | Feb 8, 2031 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/342
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
According to the method of evaluating prostatic disease of the present invention, amino acid concentration data on concentration values of amino acids in blood collected from a subject to be evaluated is measured, and the state of prostatic disease including at least one of prostatic cancer and prostatic hypertrophy in the subject is evaluated based on the concentration value of at least one of Tau, Thr, Ser, Asn, Glu, Pro, Gly, Ala, Cit, ABA, Val, Met, Ile, Leu, Phe, His, Trp, Orn, Lys, and Cys2 contained in the measured amino acid concentration data of the subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.